1. From the Nottingham Clinical Trials Unit (P.J.G., L.D., A.A.M.), University of Nottingham, United Kingdom
2. Stroke Trials Unit, Division of Clinical Neuroscience (P.J.G., P.M.B.), University of Nottingham, United Kingdom
3. Department of Neurology and Neurosurgery (A.A.), University Medical Center Utrecht, Utrecht University, the Netherlands
4. Julius Center for Health Sciences and Primary Care (A.A., J.P.G.), University Medical Center Utrecht, Utrecht University, the Netherlands
5. Department of Internal Medicine (E.B.), Oslo University Hospital, Norway
6. Stroke Research Group, UCL Institute of Neurology, UCL, London, United Kingdom (M.M.B.)
7. The George Institute for Global Health, University of NSW, Sydney, Australia (J.C.)
8. Department of Public Health and Community Medicine, Tufts University, Boston, MA (M.E.)
9. Department of Medical Statistics, LSHTM, London, United Kingdom (J.G.)
10. Medical School, The University of Western Australia, Perth (G.J.H.)
11. Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan (N.H.)
12. Dell Medical School, The University of Texas at Austin (S.C.J.)
13. Diabetes Research Centre, University of Leicester, United Kingdom (E.P.)
14. University of Otago, Wellington, New Zealand (A.R.)
15. Department of Haematology (P.M.S.), Oslo University Hospital, Norway
16. Department of Neurology, Stroke Unit, Hospital Josep Trueta, IDIBGI, Girona, Spain (J.S.)
17. Universitätsklinikum Essen, Klinik für Neurologie, Essen, Germany (C.W.).